Skip to main content

Table 5 Therapeutic approaches for Alzheimer’s disease: focusing on microbiota and gram-negative bacteria-derived molecules

From: Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications

Therapeutic methods

Treatment or drug

Subject or model

Target (or antibiotic range)

Effects or trial phase

References

Antibiotics

Doxycycline

APP/PS1 mice

Gram-positive bacteria

Gram-negative bacteria

Cognitive dysfunction↓

Neuroinflammation↓

[187]

Gentamicin, Vancomycin, Metronidazole, Neomycin, Ampicillin, Kanamycin, Colistin, and Cefaperazone

APP/PS1 mice

Gram-positive bacteria

Gram-negative bacteria

Aβ deposition↓

Soluble Aβ↓

Neuronal loss↓

Gliosis↓

[188]

Rifampicin

AD patients

Gram-positive bacteria

Gram-negative bacteria

Phase 2

NCT03856359

Doxycycline

Rifampicin

AD patients

Gram-positive bacteria

Gram-negative bacteria

Phase 3

NCT00439166

Doxycycline

Rifampicin

AD patients

Gram-positive bacteria

Gram-negative bacteria

Phase 3

NCT00715858

Minocycline

AD patients

Gram-positive bacteria

Gram-negative bacteria

Phase 2

NCT01463384

Doxycycline

Rifampicin

AD patients

Gram-positive bacteria

Gram-negative bacteria

Dysfunctional behavior↓

Cognitive dysfunction↓

[189]

Gingipain inhibitor

COR271

COR286

COR388

BALB/c mice

Gingipain

Aβ deposition↓

TNF-α↓

Neuronal loss↓

[59]

COR388

AD patients

Gingipain

Phase 2/3

NCT03823404

Probiotics

Lactobacillus acidophilus

Bifidobacterium bifidum

Bifidobacterium

longum

Aβ-administered rats

Intestinal microbiota

Cognitive dysfunction↓

LTP↑

[190]

Bifidobacterium longum

Lactobacillus acidophilus

APP/PS1 mice

Intestinal microbiota

Cognitive dysfunction↓

Aβ deposition↓

[191]

Lactobacillus plantarum MTCC1325

D-galactose-induced AD albino rats

Intestinal microbiota

Aβ deposition↓

NFT↓

Cognitive dysfunction↓

Acetylcholine level↑

[192]

Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, Lactobacillus fermentum

AD patients

Intestinal microbiota

MMSE score↑

[193]

Lactobacillus casei W56, Lactococcus lactis W19, Lactobacillus acidophilus W22, Bifidobacterium lactis W52, Lactobacillus paracasei W20, Lactobacillus plantarum W62, Bifidobacterium lactis W51, Bifidobacterium bifidum W23, Lactobacillus salivarius W24

AD patients

Intestinal microbiota

Systemic inflammation↓

[194]

Lactobacillus acidophilus, Bifidobacterium bifidum, Bifidobacterium longum

AD patients

Intestinal microbiota

MMSE score↑

[195]

Lactobacillus fermentum, Lactobacillus plantarum, Bifidobacterium lactis Lactobacillus acidophilus, Bifidobacterium bifidum, Bifidobacterium longum

AD patients

Intestinal microbiota

Cognitive dysfunction-

[196]

Intestinal microbiota reconstruction

Mediterranean-style diet

MCI patients

Non-specific bacteria

Changes of the microbiota

[157]

Mediterranean-style diet

MCI patients

Non-specific bacteria

Changes of the microbiota

[197]

Curcumin

APP/PS1 mice

Non-specific bacteria

Cognitive impairment↓

Aβ deposition↓

Changes of the microbiota

[198]

Folate and vitamin B-12

Aβ-administered rats

Non-specific bacteria

Changes of the microbiota

[199]

Ginsenoside Rg1

Tree shrew model of AD

Non-specific bacteria

Aβ deposition↓

Phosphorylated tau↓

Pro-apoptotic factor↓

Changes of the microbiota

[200]

Streptococcus thermophilus, Bifidobacteria longum, Bifidobacteria breve, Bifidobacteria infantis, Lactobacillus acidophilus, Lactobacillus plantarum,Lactobacillus paracasei, Lactobacillus delbrueckii subsp, Bulgaricus, Lactobacillus brevis

3xTg mice

Intestinal microbiota

Cognitive impairment↓

Aβ deposition↓

Neuronal loss↓

[201]

NK46 (Bifidobacterium longum) oral administration

5xFAD mice

Gram-negative bacteria

Pro-inflammatory cytokines↓

LPS↓

Gliosis↓

Neuronal loss↓

Aβ↓

Cognitive dysfunction↓

[23]

Fecal microbiota transplant

ADLPAPT mice

Microbiota dysbiosis

Aβ deposition↓

NFT↓

Neuroinflammation↓

Cognitive dysfunction↓

[202]

Fecal microbiota transplant

AD patients

Microbiota dysbiosis

MMSE score↑

[203]

Fecal microbiota transplant

AD patients

Microbiota dysbiosis

Phase 1

NCT03998423

  1. Ach Acetylcholine, AD Alzheimer’s disease, Amyloid-β, LPS lipopolysaccharides, LTP long-term potentiation, MCI mild cognitive impairment, MMSE mini-mental state examination, NFT neurofibrillary tangles, NF-kB nuclear factor-κB, SADAScog standardized Alzheimer’s disease assessment scale cognitive subscale